
Where Are We Headed with Endoscopic Spine Surgery
is_pen_killer
Description
<p>Featuring: Jin Sun Kim, MD and Michael Y. Wang, MD</p> <p><br></p> <p>Disclosures:</p> <p>Kim, Jin Sun: Stock Ownership: Innovasive (1%); Consulting: Richard Wolf (Travel Expense Reimbursement), Elliquence (Travel Expense Reimbursement); Scientific Advisory Board: Innovasive (Nonfinancial); Grants: AOSpine (A).</p> <p>Wang, Michael Y.: Royalties: DePuy Synthes Spine (F); Stock Ownership: ISD (1%), Medical Device Partners (1%); Consulting: Stryker (C), Spineology (C), K2M (C), DePuy Synthes (C); Scientific Advisory Board: Vallum (A). </p> <p>Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+</p>
Uploader
Episodes
Where Are We Headed with Endoscopic Spine Surgery
is_pen_killer